Evidence map›Paper›PMID 39519440›Full record

ArticleNutrients2024

Mediterranean Diet Is a Predictor of Progression of Subclinical Atherosclerosis in a Mediterranean Population: The ILERVAS Prospective Cohort Study.

Marina Idalia Rojo-López, Marcelino Bermúdez-López, Eva Castro, Cristina Farràs, Gerard Torres, Reinald Pamplona, Albert Lecube, José Manuel Valdivieso, Elvira Fernández, Josep Julve and 9 more

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marina Idalia Rojo-LópezInstitut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Marcelino Bermúdez-LópezVascular and Renal Translational Research Group, IRBLleida, Renal Research Network (RedInRen. ISCIII), 25198 Lleida, Spain.ORCID 0000-0002-3188-4158
Eva CastroVascular and Renal Translational Research Group, IRBLleida, Renal Research Network (RedInRen. ISCIII), 25198 Lleida, Spain.
Cristina FarràsCentre d'Atenció Primària Cappont, Gerència Territorial de Lleida, Institut Català de la Salut, 08007 Barcelona, Spain.
Gerard TorresDepartment of Respiratory Medicine, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.ORCID 0000-0002-1417-7320
Reinald PamplonaDepartment of Experimental Medicine, University of Lleida, 25198 Lleida, Spain.ORCID 0000-0003-4337-6107
Albert LecubeDepartment of Endocrinology and Nutrition, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.ORCID 0000-0001-9684-0183
José Manuel ValdiviesoVascular and Renal Translational Research Group, IRBLleida, Renal Research Network (RedInRen. ISCIII), 25198 Lleida, Spain.
Elvira FernándezVascular and Renal Translational Research Group, IRBLleida, Renal Research Network (RedInRen. ISCIII), 25198 Lleida, Spain.
Josep JulveInstitut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0002-6531-2246
Esmeralda CastelblancoDepartment of Internal Medicine, Endocrinology, Metabolism and Lipid Research Division, Washington University School of Medicine, St. Louis, MO 63110, USA.ORCID 0000-0002-2061-6270
Nuria AlonsoCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 08041 Barcelona, Spain.
Maria AntentasInstitut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.
Maria Barranco-AltirribaDepartament of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain.
Alexandre Perera-LlunaDepartament d'Enginyeria de Sistemes, Automàtica i Informàtica Industrial, Universitat Politècnica de Catalunya, B2SLab, 08034 Barcelona, Spain.ORCID 0000-0001-6427-851X
Josep Franch-NadalCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 08041 Barcelona, Spain.ORCID 0000-0002-5175-1555
Minerva Granado-CasasCIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III (ISCIII), 08041 Barcelona, Spain.ORCID 0000-0003-3447-5728
Didac MauricioInstitut de Recerca Sant Pau (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain.ORCID 0000-0002-2868-0250
On Behalf Of The Ilervas Project Collaborators

Funding

CIBER-Consorcio Centro de Investigación Biomédica en Red CB15/00071Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2021-2024 of Generalitat de Catalunya SLT017/20/000107
6 · The paper itself

Abstract

Atherosclerotic cardiovascular disease remains a major health issue, often developing silently as subclinical atherosclerotic disease (SAD). The Mediterranean diet (MDiet) is known for its cardiovascular benefits, but the combined influence of both MDiet adherence and physical activity (PA) on SAD progression has not been previously documented.

Indexed as

AtherosclerosisDiet, MediterraneanDisease ProgressionExerciseAdultAgedFemaleHealthy LifestyleHumansMaleMiddle AgedPlaque, AtheroscleroticProspective StudiesRisk Factorsatherosclerotic plaquelifestyle scoreMediterranean dietphysical activitysubclinical atherosclerosis

Identifiers

PMID39519440
PMCPMC11547874

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.